Literature DB >> 2982832

Amplification and purification of the bacteriophage Mu encoded B transposition protein.

G Chaconas, G Gloor, J L Miller.   

Abstract

The A and B proteins encoded by the temperate bacteriophage Mu are involved in the high efficiency DNA transposition reaction which is the distinguishing feature of this phage. The genes encoding these early proteins were cloned in an expression vector under the control of the bacteriophage lambda leftward promoter. Under optimal conditions gpB was overproduced to account for 15% of the total cellular protein. The protein was purified to near homogeneity as determined by silver staining. Sequence analysis of the N terminus confirmed the identity of the purified protein as gpB. Proteolytic processing of the B protein does not occur at the amino terminus; the terminal methionine residue is quantitatively deformylated. The protein, which was found to be basic and a general DNA binding protein, was insoluble at low ionic strength in the absence, but not in the presence, of DNA. The B protein also displayed a tendency to aggregate at high ionic strength where it was soluble in the absence of DNA. In addition, the protein was characterized as to its amino acid composition and extinction coefficient at 280 nm. The purified protein is active in a soluble in vitro transposition-replication system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982832

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  The solution structure of the C-terminal domain of the Mu B transposition protein.

Authors:  L H Hung; G Chaconas; G S Shaw
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

2.  Conformational isomerization in phage Mu transpososome assembly: effects of the transpositional enhancer and of MuB.

Authors:  M Mizuuchi; K Mizuuchi
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

3.  Purification and characterization of TnsC, a Tn7 transposition protein that binds ATP and DNA.

Authors:  P Gamas; N L Craig
Journal:  Nucleic Acids Res       Date:  1992-05-25       Impact factor: 16.971

4.  MuA-mediated in vitro cloning of circular DNA: transpositional autointegration and the effect of MuB.

Authors:  Elsi Pulkkinen; Saija Haapa-Paananen; Harri Savilahti
Journal:  Mol Genet Genomics       Date:  2016-02-04       Impact factor: 3.291

5.  DNase protection analysis of the stable synaptic complexes involved in Mu transposition.

Authors:  M Mizuuchi; T A Baker; K Mizuuchi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

6.  Frameshift mutations in the bacteriophage Mu repressor gene can confer a trans-dominant virulent phenotype to the phage.

Authors:  V Geuskens; J L Vogel; R Grimaud; L Desmet; N P Higgins; A Toussaint
Journal:  J Bacteriol       Date:  1991-10       Impact factor: 3.490

7.  MuB is an AAA+ ATPase that forms helical filaments to control target selection for DNA transposition.

Authors:  Naoko Mizuno; Marija Dramićanin; Michiyo Mizuuchi; Julia Adam; Yi Wang; Yong-Woon Han; Wei Yang; Alasdair C Steven; Kiyoshi Mizuuchi; Santiago Ramón-Maiques
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

8.  A new set of Mu DNA transposition intermediates: alternate pathways of target capture preceding strand transfer.

Authors:  D Z Naigamwalla; G Chaconas
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

9.  Secondary structural features of the bacteriophage Mu-encoded A and B transposition proteins.

Authors:  G Chaconas; W D McCubbin; C M Kay
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

10.  Interactions of the transposase with the ends of Mu: formation of specific nucleoprotein structures and non-cooperative binding of the transposase to its binding sites.

Authors:  M A Groenen; M Vollering; P Krijgsman; K van Drunen; P van de Putte
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.